SGLT2 inhibitors and renal complications in type 1 diabetes

Petrie, J. R. (2020) SGLT2 inhibitors and renal complications in type 1 diabetes. Lancet Diabetes and Endocrinology, 8(10), pp. 803-805. (doi: 10.1016/S2213-8587(20)30311-9) (PMID:32946814) (PMCID:PMC7492012)

[img] Text
226416.pdf - Accepted Version
Available under License Creative Commons Attribution Non-commercial No Derivatives.



No abstract available.

Item Type:Articles
Glasgow Author(s) Enlighten ID:Petrie, Professor John
Authors: Petrie, J. R.
College/School:College of Medical Veterinary and Life Sciences > School of Cardiovascular & Metabolic Health
Journal Name:Lancet Diabetes and Endocrinology
Publisher:Lancet Publishing Group
ISSN (Online):2213-8595
Published Online:15 September 2020
Copyright Holders:Copyright © 2020 Elsevier
First Published:First published in Lancet Diabetes and Endocrinology 8(10):803-805
Publisher Policy:Reproduced in accordance with the copyright policy of the publisher

University Staff: Request a correction | Enlighten Editors: Update this record